Fecal incontinence
Drug research and approvals for fecal incontinence: what is recruiting, what Health Canada authorized, FDA orphan designations and EU medicines. See every condition.
As of Nov 21, 2026, 47 studies of fecal incontinence are recruiting on ClinicalTrials.gov, Health Canada has authorized 0 drug trials for it since 2013, and FDA has 0 approved and 1 open orphan designations naming it.
- Recruiting worldwide: 47
- Trials authorized in Canada: 0
- FDA orphan approvals: 0
- EU medicines: 0
- Ultrasound Assessment After Surgery for Chronic Anal FissureNCT07809711 · Not reported · Hospital Clínico Universitario de Valencia · starts Oct 12, 2024
- Aerobic Exercise and Guided Imagery in Low Anterior Resection SyndromeNCT07732894 · Not applicable · Biruni University · starts Dec 30, 2025
- Postpartum Health Trajectories the First Year After Obstetric Anal Sphincter Injury and the Impact of a Group-Based…NCT07667660 · Not applicable · Hanna Jangö · starts Sep 14, 2026
- Efficacy and Safety of Transcutaneous Posterior Tibial Nerve Stimulation on Fecal Continence in Patients Undergoing…NCT07632196 · Not applicable · Althaia Xarxa Assistencial Universitària de Manresa · starts Feb 6, 2026
- Active Versus Passive Anal Sphincter Training in Patients With Fecal IncontinenceNCT07604415 · Not applicable · University Hospital, Martin · starts May 15, 2026
- Understanding and Tailored Treatment of Low Anterior Resection SyndromeNCT07573371 · Not reported · Aalborg University Hospital · starts Sep 17, 2024
- The Voided Urinary, Perineal, and Faecal Microbiota Among Children and Adolescents - the PpUF-study.NCT07535619 · Not reported · Aalborg University Hospital · starts Dec 14, 2022
- Improving the Care of Incontinence-Associated Dermatitis (IAD) Using a Beta-Glucan Cream as a Hydrating and Soothing…NCT07524439 · Not applicable · University of Alberta · starts May 1, 2026
- Comparison of Lateral Internal Sphincterotomy Techniques for Chronic Anal FissureNCT07520552 · Not applicable · Çanakkale Onsekiz Mart University · starts May 6, 2026
Phase 3 7
- ClonidineAdrenergic receptor alpha-2 agonist
- OnabotulinumtoxinaSynaptosomal nerve-associated protein 25 (SNAP-25) inhibitor
- LoperamideMu opioid receptor agonist
- Iltamiocel
- MetronidazoleDNA inhibitor
- PhenylephrineAdrenergic receptor alpha-1 agonist
- ColesevelamBile acids sequestering agent
Phase 2 3
- MethoxamineAdrenergic receptor alpha-1 agonist
- Plantago seed
- RamosetronSerotonin 3 (5-HT3) receptor antagonist
Phase 1 or earlier 1
- OxymetazolineAdrenergic receptor alpha agonist
How its trials ended
290 ClinicalTrials.gov studies of the condition, classified by TrialPanorama, partly automatically, so some labels are wrongOf the 58 whose ending is known, 31% met their primary endpoint, 9% missed it and 60% stopped early.
- Completed, result not reported13747%
- Ongoing5720%
- Status unknown3813%
- Stopped: other or unclear217%
- Met its primary endpoint186%
- Stopped: enrollment or feasibility83%
- Missed its primary endpoint52%
- Stopped: lack of efficacy41%
- Stopped: sponsor or business decision1<1%
- Stopped: funding1<1%
| Date | Drug | Sponsor | Status |
|---|---|---|---|
| Feb 14, 2002 | PhenylephrineTreatment of ileal pouch anal anastomosis related fecal incontinence | S.L.A. Pharma | Designated |
Condition names come from Health Canada's trial database. Orphan designations and EU medicines are matched when their indication names the condition as whole words, so a broader or differently worded indication can be missed. Recruiting counts are live from ClinicalTrials.gov's own condition search, refreshed daily. ClinicalTrials.gov, Health Canada Clinical Trials Database, FDA orphan designations, EMA